Sunil Gupta

Title: Sunil Gupta: Innovator in Antitumoral Treatments

Introduction

Sunil Gupta is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of prostate cancer. His innovative approach focuses on the use of specific compounds to enhance treatment efficacy for patients who are not responsive to traditional therapies.

Latest Patents

Sunil Gupta holds a patent for the "Antitumoral use of cabazitaxel." This invention relates to a compound that may exist in base form, as a hydrate, or as a solvate. It is designed to be used in combination with prednisone or prednisolone as a medicament for treating prostate cancer, especially metastatic prostate cancer. This treatment is particularly beneficial for patients who do not respond to taxane-based treatments.

Career Highlights

Sunil Gupta is associated with Aventis Pharma S.A., where he has contributed to the development of innovative pharmaceutical solutions. His work has focused on improving treatment options for cancer patients, showcasing his commitment to advancing medical science.

Collaborations

[Section skipped due to space constraints.]

Conclusion

Sunil Gupta's contributions to antitumoral treatments highlight his role as an innovator in the medical field. His patent for the use of cabazitaxel represents a significant advancement in the fight against prostate cancer.